Decreased heart rate recovery in patients with heart failure - Effect of fluvastatin therapy

被引:11
作者
Katircibasi, MT
Canatar, T
Kocum, HT
Erol, T
Tekin, G
Demircan, S
Tekin, A
Sezgin, AT
Baltali, M
Muderrisoglu, H
机构
[1] Baskent Univ, Adana Uygulama Arastirma Hastanesi Kardiyol, Dept Cardiol, TR-01250 Adana, Turkey
[2] Baskent Univ, Adana Uygulama Arastirma Hastanesi Kardiyol, Dept Family Med, Sch Med, TR-01250 Adana, Turkey
关键词
heart rate recovery; fluvastatin; heart failure;
D O I
10.1536/ihj.46.845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart rate recovery is the difference in heart rate at peak exercise and at a specific time interval following the onset of recovery. Attenuated heart rate recovery is an independent predictor of mortality in patients with a history of coronary artery disease. The aim of the present study was to evaluate the effect of a statin on heart rate recovery, particularly in patients with ischemic heart failure and hyperlipidemia. Twenty-nine consecutive hyperlipidemic, stable coronary artery disease patients with heart failure and 19 healthy subjects were enrolled. Heart rate recovery values at the 1st and 3rd minutes and lipid profiles of the patients were evaluated at baseline and following 3 months of treatment with fluvastatin. Compared with healthy subjects, the heart rate recovery values were significantly lower in the heart failure patients in both the 1st and 3rd minutes, respectively (31 +/- 6 versus 19 +/- 7, P < 0.0001; 66 +/- 7 versus 47 +/- 8, P < 0.0001). Heart rate recovery in the 1st and 3rd minutes increased from 19 +/- 7 to 24 +/- 9 and 47 +/- 8 to 57 +/- 11, respectively, following treatment (P < 0.001, P < 0.001). There were no significant correlations among the changes in lipid parameters or HRR in the first and third minutes in the recovery period. The results revealed an improvement in heart rate recovery in heart failure patients by fluvastatin treatment. If this association can be confirmed by other studies, it would be interesting to perform further studies into the mechanism underlying this finding.
引用
收藏
页码:845 / 854
页数:10
相关论文
共 50 条
[1]   Modulation of renal oxygen consumption by nitric oxide is impaired after development of congestive heart failure in dogs [J].
Adler, S ;
Huang, H ;
Loke, K ;
Xu, XB ;
Laumas, A ;
Hintze, TH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (03) :301-309
[2]   Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors [J].
Alfon, J ;
Guasch, JF ;
Berrozpe, M ;
Badimon, L .
ATHEROSCLEROSIS, 1999, 145 (02) :325-331
[3]   MODULATION OF CARDIAC AUTONOMIC ACTIVITY DURING AND IMMEDIATELY AFTER EXERCISE [J].
ARAI, Y ;
SAUL, JP ;
ALBRECHT, P ;
HARTLEY, LH ;
LILLY, LS ;
COHEN, RJ ;
COLUCCI, WS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01) :H132-H141
[4]  
BAINS JS, 1994, REGUL PEPTIDES, V50, P53
[5]   Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis [J].
Baller, D ;
Notohamiprodjo, G ;
Gleichmann, U ;
Holzinger, J ;
Weise, R ;
Lehmann, J .
CIRCULATION, 1999, 99 (22) :2871-2875
[6]   Effect of pharmacological wash-out in patients undergoing exercise testing after acute myocardial infarction [J].
Bigi, R ;
Verzoni, A ;
Cortigiani, L ;
De Chiara, B ;
Desideri, A ;
Fiorentini, C .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 (02) :277-281
[7]   HEPATIC AND NONHEPATIC STEROL SYNTHESIS AND TISSUE DISTRIBUTION FOLLOWING ADMINISTRATION OF A LIVER SELECTIVE HMG-COA REDUCTASE INHIBITOR, CI-981 - COMPARISON WITH SELECTED HMG-COA REDUCTASE INHIBITORS [J].
BOCAN, TMA ;
FERGUSON, E ;
MCNALLY, W ;
UHLENDORF, PD ;
MUELLER, SB ;
DEHART, P ;
SLISKOVIC, DR ;
ROTH, BD ;
KRAUSE, BR ;
NEWTON, RS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1123 (02) :133-144
[8]   Interactions between angiotensin II and the sympathetic nervous system in the the long-term control of arterial pressure [J].
Brooks, VL .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (01) :83-90
[9]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[10]   Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort [J].
Cole, CR ;
Foody, JM ;
Blackstone, EH ;
Lauer, MS .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (07) :552-555